Abstract
THIS laboratory has previously reported that β-diethylaminoethyl diphenylpropylacetate hydrochloride (SKF 525-A) potentiates the pharmacological activity of a variety of drugs by interfering with their rate of detoxication1,2. Recently, we have become interested in the potentiating effects of chlorpromazine and reserpine, drugs widely used for their tranquillizing effects. Chlorpromazine is reported to potentiate the action of a number of central depressant drugs, including barbiturates and ethanol3. We have been able to show that reserpine as well as chlorpromazine potentiates the hypnotic action of hexobarbitone and ethanol; and furthermore, that neither potentiating agent influences the rate of metabolic transformation of the hypnotics but acts presumably by increasing the sensitivity of the central nervous system.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
